Arena Pharmaceuticals appoints Kevin R. Lind as chief financial officer
Arena Pharmaceuticals has announced that Kevin R. Lind will join its management team as executive vice president and chief financial officer, effective June 15, 2016. Lind will report to Amit D. Munshi, Arena's president and chief executive officer.
"Kevin is an accomplished executive with significant financial expertise and will be an exceptional addition to our team," said Munshi. "Kevin's broad finance experience in the healthcare environment will be an asset to us as we move toward implementing a streamlined, flexible cost structure and operating model, while enabling us to focus on our highest-potential value-driving opportunities."
Mr. Lind joins Arena with over 15 years of experience in healthcare banking and private equity. Prior to Arena, Lind was at TPG, most recently as a principal at TPG Special Situations Partners and initially atTPG-Axon's Pharma Partners group. Lind started his career in various capacities as a healthcare investment banker at Lehman Brothers. Lind received a B.S. from Stanford University in Biological Sciences and an M.B.A. from UCLA Anderson School of Management.
"It is a tremendous opportunity to join Arena at such an exciting time," said Lind. "I believe Arena's pipeline has great potential with its current phase II programs and I look forward to joining Arena's executive team to assist in delivering significant value to patients and shareholders."